Lv1
40 积分 2025-09-01 加入
A Novel Therapeutic Anti-ErbB3, ISU104 Exhibits Potent Antitumorigenic Activity by Inhibiting Ligand Binding and ErbB3 Heterodimerization
1天前
待确认
Combining chemotherapy and immunotherapy for advanced anal cancer: are we ready?
1个月前
已完结
Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy
3个月前
已完结
Aspirin and recurrence of PI3K-mutated CRC
3个月前
已完结
The ErbB family and androgen receptor signaling are targets of Celecoxib in prostate cancer
3个月前
已完结
Dual EGFR and COX-2 inhibition as a novel approach to targeting head and neck squamous cell carcinoma
3个月前
已完结
Regulation of cyclooxygenase-2 pathway by HER2 receptor
3个月前
已完结
Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer
3个月前
已完结
The single N-glycan deletion mutant of soluble ErbB3 protein attenuates heregulin β1-induced tumor progression by blocking of the HIF-1 and Nrf2 pathway
3个月前
已完结
A systematic review and meta-analysis of randomized trials on the role of targeted therapy in the management of advanced gastric cancer: Evidence does not translate?
4个月前
已完结
皖公网安备34019202002308
